Sensus Healthcare, Inc.
As of Oct 22, 2026, Sensus Healthcare is in Stage 4, the downtrend phase, now in its first week (since Oct 16, 2026). It closed at $2.87, 45.8% below its 52-week high and below its 200-day average, which is falling.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is SRTS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
SRTS among Medical Devices56th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …56 | SRTS | Stage 4 · wk 1 | 46 | −5.3% |
Sensus Healthcare: quick answers
What stage is Sensus Healthcare in?
As of Oct 22, 2026, Sensus Healthcare (SRTS) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 16, 2026 and is in its first week there. What the four stages mean
Is Sensus Healthcare in an uptrend?
No. Sensus Healthcare is in a Stage 4 downtrend. It trades 20.2% below its 200-day average, which is falling.
How far is Sensus Healthcare from its 52-week high?
Sensus Healthcare closed at $2.87 on Oct 22, 2026, 45.8% below its 52-week high of $5.30. Its 52-week low is $2.69.
How has Sensus Healthcare performed over the past year?
As of Oct 22, 2026, Sensus Healthcare is down 11.1% over the past year and down 30.0% so far in 2026.
Which sector and industry is Sensus Healthcare in?
Sensus Healthcare is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.